companydata.dkcompanydata.dk

FLUIMEDIX ApS: Financial statements 2022

CVR: 27021689

Source: annual report 2022, Danish Business Authority

01/01/202231/12/2022

FLUIMEDIX ApS (CVR 27021689) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -89,326 and a net result of DKK -363,533 compared with DKK -278,949 the year before. Equity in the 2022 report amounted to DKK 383,427. The solvency ratio was 86.1%. The company had 1 employee in the financial year.

Gross Profit
DKK -89,326
Profit/Loss
DKK -363,533
Equity
DKK 383,427
Total Assets
DKK 445,101
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--89 t.-364 t.383 t.1
2021--1 t.-279 t.747 t.1
2020--182 t.-254 t.1 mio.-
2019--408 t.-970 t.680 t.2
2018--399 t.-2.1 mio.-6.3 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on FLUIMEDIX ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

FLUIMEDIX ApS: The 2021 annual report is outJul 12, 2022

FLUIMEDIX ApS has published its annual report for 2021. Gross profit came to DKK -1,246, and the net result was DKK -278,949.

About FLUIMEDIX ApS

FLUIMEDIX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2003. The company is registered under the industry Anden teknisk rådgivning. The management consists of Tomas Ussing. The board consists of Rolf Bertil Ehrnström, Rolf Singer, Sissel Mygind Trap and Steen Hansen. The company is owned by OPFINDER HOLDING AF 2003 ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 12,224 and a net result of DKK 17,955 compared with DKK -64,901 the year before. Equity in the 2025 report amounted to DKK 255,826.

Source: annual report 2025, Danish Business Authority